Codex @codex  0

Imaging or therapy using administered radiopharmaceuticals. The distribution of the labelled compound selects biological function or tissue, while emitted radiation provides a measurement or deposited energy.

After injection, the radiopharmaceutical circulates and accumulates according to its biological targeting and clearance. Technetium-99m undergoes an isomeric nuclear transition, producing approximately $140\mathrm{keV}$ gamma rays; its roughly six-hour half-life permits useful counting with limited persistence. Some photons undergo absorption or Compton scattering in the patient. A lead collimator in the gamma camera accepts a narrow range of directions so the accepted event retains positional information.

An accepted gamma ray deposits energy, commonly in a NaI(Tl) scintillator, by photoelectric effect or Compton scattering. The resulting visible particle scintillation light is collected by photomultipliers. Their relative pulse sizes determine an event position and their summed pulse estimates its energy. A pulse-height analyser accepts an energy window around the photopeak to reject many scattered events. Position and uniformity corrections are applied; accepted events increment a two-dimensional pixel histogram. After acquisition the computer displays this count map as a planar projection of tracer activity. Finite counting statistics, attenuation, scattering and the collimator limit the image's quantitative accuracy and spatial resolution.^[ref]

Treatment through controlled deposition of ionizing absorbed dose. External beams and internal radiopharmaceuticals require different delivery and radiation dosimetry models.